NCT00006221View on ClinicalTrials.gov

BMS-247550 in Treating Patients With Advanced Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

June 30, 2005

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

ixabepilone

Trial Locations (3)

78229

Cancer Therapy and Research Center, San Antonio

Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006221 - BMS-247550 in Treating Patients With Advanced Cancers | Biotech Hunter | Biotech Hunter